172 related articles for article (PubMed ID: 21876641)
1. Imiquimod 3.75% cream applied daily to treat anogenital warts: combined results from women in two randomized, placebo-controlled studies.
Baker DA; Ferris DG; Martens MG; Fife KH; Tyring SK; Edwards L; Nelson A; Ault K; Trofatter KF; Liu T; Levy S; Wu J
Infect Dis Obstet Gynecol; 2011; 2011():806105. PubMed ID: 21876641
[TBL] [Abstract][Full Text] [Related]
2. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ
Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
[TBL] [Abstract][Full Text] [Related]
3. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
[TBL] [Abstract][Full Text] [Related]
4. Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations.
Sauder DN; Skinner RB; Fox TL; Owens ML
Sex Transm Dis; 2003 Feb; 30(2):124-8. PubMed ID: 12567169
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts--results of an open-label, multicentre Phase IIIB trial.
Garland SM; Sellors JW; Wikstrom A; Petersen CS; Aranda C; Aractingi S; Maw RD;
Int J STD AIDS; 2001 Nov; 12(11):722-9. PubMed ID: 11589811
[TBL] [Abstract][Full Text] [Related]
6. A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.
Gilson RJ; Shupack JL; Friedman-Kien AE; Conant MA; Weber JN; Nayagam AT; Swann RV; Pietig DC; Smith MH; Owens ML
AIDS; 1999 Dec; 13(17):2397-404. PubMed ID: 10597781
[TBL] [Abstract][Full Text] [Related]
7. Topical imiquimod: a review of its use in genital warts.
Perry CM; Lamb HM
Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod 5% cream in the treatment of anogenital warts in female patients.
Buck HW; Fortier M; Knudsen J; Paavonen J
Int J Gynaecol Obstet; 2002 Jun; 77(3):231-8. PubMed ID: 12065134
[TBL] [Abstract][Full Text] [Related]
9. Imiquimod cream 2.5% and 3.75% applied once daily to treat external genital warts in men.
Rosen T; Nelson A; Ault K
Cutis; 2015 Oct; 96(4):277-82. PubMed ID: 26682290
[TBL] [Abstract][Full Text] [Related]
10. Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.
Hoyme UB; Hagedorn M; Schindler AE; Schneede P; Hopfenmüller W; Schorn K; Eul A
Infect Dis Obstet Gynecol; 2002; 10(2):79-88. PubMed ID: 12530484
[TBL] [Abstract][Full Text] [Related]
11. An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women.
Garland SM; Waddell R; Mindel A; Denham IM; McCloskey JC
Int J STD AIDS; 2006 Jul; 17(7):448-52. PubMed ID: 16820073
[TBL] [Abstract][Full Text] [Related]
12. Topical imiquimod 5% cream in external anogenital warts: a randomized, double-blind, placebo-controlled study.
Arican O; Guneri F; Bilgic K; Karaoglu A
J Dermatol; 2004 Aug; 31(8):627-31. PubMed ID: 15492435
[TBL] [Abstract][Full Text] [Related]
13. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
[TBL] [Abstract][Full Text] [Related]
14. Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
Diamantis ML; Bartlett BL; Tyring SK
Skin Therapy Lett; 2009 Jun; 14(5):1-3, 5. PubMed ID: 19609471
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of daily self-application of imiquimod 3.75% cream in adult patients with external anogenital warts.
Wu J; Feldman R; Barry GT; Kulp J; Adams MP; Levy S
J Clin Pharmacol; 2012 Jun; 52(6):828-36. PubMed ID: 22232733
[TBL] [Abstract][Full Text] [Related]
16. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day.
Fife KH; Ferenczy A; Douglas JM; Brown DR; Smith M; Owens ML;
Sex Transm Dis; 2001 Apr; 28(4):226-31. PubMed ID: 11318254
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts.
Komericki P; Akkilic-Materna M; Strimitzer T; Aberer W
Sex Transm Dis; 2011 Mar; 38(3):216-8. PubMed ID: 20938374
[TBL] [Abstract][Full Text] [Related]
18. Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study.
Syed TA; Hadi SM; Qureshi ZA; Ali SM; Kwah MS
J Infect; 2000 Sep; 41(2):148-51. PubMed ID: 11023759
[TBL] [Abstract][Full Text] [Related]
19. Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
Syed TA; Ahmadpour OA; Ahmad SA; Ahmad SH
J Dermatol; 1998 Jul; 25(7):429-33. PubMed ID: 9714974
[TBL] [Abstract][Full Text] [Related]
20. Imiquimod 5% cream is an acceptable treatment option for external anogenital warts in uncircumcised males.
Maw RD; Kinghorn GR; Bowman CA; Goh BT; Nayagam AT; Nathan M
J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):58-62. PubMed ID: 11952292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
